Our story.
VivoXpand grew out of VivoArchitect, the contract research organisation (CRO) our founder, Alberto Parras, set up at Biopôle Lausanne to run in vivo aging studies for biotech and pharma companies.
Running those studies showed us a gap. Few longevity products sold to consumers had ever been tested the way the industry tests its own candidates: in living organisms, with physiologically relevant readouts. So we built a company to make them. That company is VivoXpand.
The two companies have the same founder but different roles. VivoXpand develops, formulates and owns its products, and all our intellectual property is held by our Spanish company, VivoArchitect Ibérica, S.L., in Sevilla. VivoArchitect remains our CRO: it runs our in vivo studies as a paid service provider and holds none of our IP.
Biotech rigour at consumer speed.
